(Q50697363)

17 March 2018

title

Challenges associated with the evaluation of veterinary product bioequivalence: an AAVPT perspective. (English)

1 reference

17 March 2018

author name string

Martinez M

1

1 reference

17 March 2018

Langston C

2

1 reference

17 March 2018

Martin T

3

1 reference

17 March 2018

Conner D

4

1 reference

17 March 2018

publication date

1 June 2002

1 reference

17 March 2018

Journal of Veterinary Pharmacology and Therapeutics

published in

1 reference

17 March 2018

volume

25

1 reference

17 March 2018

issue

3

1 reference

17 March 2018

page(s)

201-220

1 reference

17 March 2018

A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Gastric emptying of tablets and granules in humans, dogs, pigs, and stomach-emptying-controlled rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Statistical comparison of dissolution curves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Bioequivalence: performance of several measures of extent of absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Coverage and precision of confidence intervals for area under the curve using parametric and non-parametric methods in a toxicokinetic experimental design

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Maximum entropy and its application to the calculation of drug absorption rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Sex differences in the disposition of albendazole metabolites in sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Planning and monitoring of equivalence studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Polysorbate Toxicity in Neonatal Rats and Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

21 January 2018

Drug metabolite kinetics

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

In vitro and in vivo evaluation in dogs and pigs of a hydrophilic matrix containing propylthiouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Bioequivalence of ivermectin formulations in pigs and cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Feasibility of interspecies extrapolation in determining the bioequivalence of animal products intended for intramuscular administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Pharmacokinetics of diflubenzuron in two types of chickens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Interim analyses for randomized clinical trials: the group sequential approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Doxycycline binding to plasma albumin of several species

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Allometric analysis of doxycycline pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Plasma protein binding displacement interactions--why are they still regarded as clinically important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

The sensitization potential of some perfume ingredients tested using a modified draize procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Plasma protein binding and pharmacological response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Controversies in Bioequivalence Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Limited-sampling strategy models for estimating the area under the plasma concentration-time curve for amlodipine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Center of gravity of drug level curves: a model-independent parameter useful in bioavailability studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Reversal of multidrug resistance by surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Can bioavailability of low-variance drugs be estimated with an unpaired, sparse sampling design?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00407.X

10.1046/J.1365-2885.2002.00407.X

21 January 2018

Identifiers

DOI

1 reference

17 March 2018

1 reference

17 March 2018